Experience in using a vitamin and mineral supplement to restore the menstrual cycle in patients with functional hyperprolactinemia
- Authors: Manukhina E.I.1, Ispas A.A.2
-
Affiliations:
- FSFEI HE Moscow A. I. Evdokimov University of Medicine and Dentistry
- City clinical hospital named after E.O. Mukhin
- Issue: No 2 (2020)
- Pages: 169-172
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248805
- DOI: https://doi.org/10.18565/aig.2020.2.169-173
- ID: 248805
Cite item
Open Access
Access granted
Abstract
Objective. To present the authors’ own experience in using a Pregnotone vitamin and mineral supplement to restore the menstrual cycle in patients with functional hyperprolactinemia. Subjects andmethods. Examinations were made in 135reproductive-aged women withfunctionalhyperprolactinemia and menstrual irregularities before and after a 3-month Pregnotone treatment cycle. Results. After a month of Pregnotone intake, 80/135 (59.2%) followed up patients reported their general health improvements (in mood and sleep); the menstrual cycle was restored and became regular in 26/135 (19.2%) cases. After completing a full (3-month) Pregnotone treatment cycle, there was a considerable health improvement in 115/135 (85.2%) cases; the menstrual cycle was noted to be restored in 110/135 (81.5%) patients. Conclusion. The balanced vitamin and mineral supplement Pregnotone has a positive effect on a woman’ general well-being (better mood and better sleep) and can be used to treat menstrual irregularities in patients with functional hyperprolactinemia. A substantial effect of Pregnotone should be expected after its 3-month treatment cycle.
Full Text
About the authors
Ekaterina I. Manukhina
FSFEI HE Moscow A. I. Evdokimov University of Medicine and Dentistry
Email: katemanu@mail.ru
MD, professor
Anastasia A. Ispas
City clinical hospital named after E.O. Mukhin
Email: ispasanastasia@mail.ru
obstetrician-gynecologist of state budgetary healthcare institution
References
- Громова О.А., Торшин И.Ю. Витамины и микронутриенты: между Сциллой и Харибдой. МЦНМО, 2013; 869
- Иловайская И.А. Диагностика и лечение гиперпролактинемии: клинические рекомендации Международного эндокринологического общества и взгляд российских экспертов. Фарматека: Акушерство и гинекология. 2012, 1: 2-7
- Famini P., Maya M.M., Melmed 5. Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J. Clin Endocrinol Metabol. 2011; 96: 1633-41. doi: 10.1210/jc.2011-0168
- Дедов И.И., Мельниченко Г.А., Романцова Т.И. Эндокринология. Национальное руководство. М.: ГЭОТАР-Медиа, 2015: 589-94.
- Дедов И.И., ред. Клиническая нейроэндокринология. М. 2011: 113-8.
- Melmed S., Casanueva F.F., Hoffman A.R. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J. Clin Endocrinol Metab. 2011; 96(2): 273-88. doi: 10.1210/jc.2010-1692.
- Подзолкова Н.М., Глазкова О.Л. Симптом, синдром, диагноз. Дифференциальная диагностика в гинекологии. [Электронный ресурс]. М.: ГЭОТАР-Медиа, 2014. 736 с. Режим доступа: https://www.rosmedlib.ru/ book/ISBN9785970426937.html.
- Ларина А.А., Григорян О.Р., Андреева Е.Н., Дзеранова Л.К. Гиперпролактинемия и беременность. Проблемы репродукции. 2013; 3: 13-17.
- Герасимович Е.М. Гормональные и метаболические нарушения при использовании препаратов заместительной гормональной терапии и препаратов растительного происхождения. Мед. новости. 2008; 1: 98-102.
- Вуттке В., Ярри Г., Зайдлова-Вуттке Д. Терапевтические возможности экстрактов из Аврамова дерева (Vitex Agnus castus) в гинекологической практике. Проблемы репродукции. 2009; 4: 53-7.
- Wu G., Bazer F.W., Satterfield M.C., LiX., Wang X., Johnson G.A., Burghardt R.C., Dai Z., Wang J., Wu Z. Impacts of arginine nutrition on embryonic and fetal development in mammals. Amino Acids. 2013; 45(2): 241-56. https://doi. org/10.1007/s00726-013-1515-z
- Babey M., Sahli R., Vajtai I., Andres R.H., Seiler R.W. Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonist. Pituitary. 2011; 14: 222-30. doi: 10.1007/s11102-010-0283-y.
Supplementary files
